Saga Full Year 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St

April 12, 2025

Saga (LON:SAGA) Full Year 2025 Results

Key Financial Results

Revenue: UK£594.4m (down 21% from FY 2024).
Net loss: UK£178.7m (loss widened by 58% from FY 2024).
UK£1.27 loss per share (further deteriorated from UK£0.81 loss in FY 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

earnings-and-revenue-growth — LSE:SAGA Earnings and Revenue Growth April 12th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Saga Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 12%. Earnings per share (EPS) missed analyst estimates by 38%.

Looking ahead, revenue is forecast to grow 1.0% p.a. on average during the next 2 years, compared to a 6.1% growth forecast for the Insurance industry in the United Kingdom.

Performance of the British Insurance industry.

The company's shares are up 17% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We have a graphic representation of Saga's balance sheet and an in-depth analysis of the company's financial position.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.